No, but some GH analogs can have performance-enhancing effects and regulatory restrictions
One company, in particular, cashed in big Houston-based Empower Pharmacy
Many peptides have not been evaluated or approved by the U.S
Common GHRPs include: CJC-1295 A long-acting peptide that boosts growth hormone levels over time, aiding in fat loss and muscle gain
Renal protection with glucagon-like peptide type 1 receptor agonists In CVOTs of arGLP1 renal outcomes were prespecified as key secondary outcomes in 4 studies done with liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatide,58,59,63,64 or were collected as safety parameters in other studies.60 Overall, the prevalence of CKD stage 3 in these studies was low (2030%) (Table 1)